| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 139 | 3,520 | 370 | $70 | $280.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 44 | 4,010 | 290 | $50 | $199.8K |
| 99392 | Preventive medicine services are provided to individuals who are not in need of any immediate medical attention, but need to undergo a periodic health checkup as a preventive measure. Well–baby… | 20 | 650 | 150 | $80 | $115.4K |
| 99391 | Preventive medicine services are provided to individuals who are not in need of any immediate medical attention, but need to undergo a periodic health checkup as a preventive measure. Well–baby… | 67 | 580 | 150 | $70 | $109K |
| 99393 | The provider performs an established well–patient visit for a child who is between the ages of 5 and 11. | 16 | 630 | 110 | $80 | $78.1K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 245 | 980 | 140 | $70 | $70.9K |
| 96110 | The provider screens the patient for a developmental disorder using a standardized instrument (such as a recognized form) focused on areas such as developmental milestones and age–appropriate… | 234 | 370 | 210 | $40 | $62.9K |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 27 | 430 | 160 | $80 | $60.2K |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 84 | 200 | 370 | $30 | $58.8K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 65 | 340 | 440 | $20 | $58K |